FDA Approved: * July 24, 2020 Pharm Company: *AMNEAL Category:Cancer
Metirosine (INN and BAN; α-Methyltyrosine, Metyrosine USAN, AMPT) is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body.
It is available as a generic medication.
1 Clinical use
2 See also
4 External links
Metirosine has been shown to suppress catecholam...
* May have multiple approval dates, manufacturers, or labelers.